Short communicationATPase activity of pharmacological preparations
References (10)
- et al.
Biochim. Biophys. Acta
(1968) - et al.
European J. Pharmacol.
(1967) - et al.
Anal. Biochem.
(1969) - et al.
Arch. Intern. Pharmacodyn.
(1970) - et al.
Acta Physiol. Scand.
(1969)
There are more references available in the full text version of this article.
Cited by (8)
Nucleoside triphosphate diphosphohydrolase-1 ectonucleotidase is required for normal vas deferens contraction and male fertility through maintaining P2X1 receptor function
2014, Journal of Biological ChemistryCitation Excerpt :We showed here that NTPDase1 deletion leads to an important reduction in the hydrolytic activity at the surface of vas deferens SMCs, especially at low micromolar concentrations of ATP. These data demonstrate that NTPDase1 is the high-affinity enzyme responsible for the main ATPase activity reported previously in this tissue (30) which is also in agreement with the immunolocalization of NTPDase1 in the vas deferens (19). NTPDase1 has been described in virtually all vascular and visceral SMCs (14, 19, 31, 32), making this enzyme the key ectonucleotidase in the regulation of P2 receptor activation on these cells and, consequently, purinergically dependent smooth muscle contraction.
Can ATP stimulate P<inf>1</inf>-receptors in guinea-pig atrium without conversion to adenosine?
1982, European Journal of PharmacologyEffects of bis(2-chloroethyl)sulfide on ATP receptor-mediated responses of the rat vas deferens: Possible relationship to cytotoxicity
1998, Journal of Pharmacology and Experimental TherapeuticsEnhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156
1996, British Journal of PharmacologyEcto‐enzymes and metabolism of extracellular ATP
1994, Drug Development ResearchEffect of Presynaptic P<inf>2</inf> Receptor Stimulation on Transmitter Release
1991, Journal of Neurochemistry
Copyright © 1972 Published by Elsevier B.V.